BICYCLE TOXIN CONJUGATES
LIVE

Serial Number

79237920

Owner

Bicycletx Limited

Attorney

Christina M. Licursi

Filing Date

Mar 9, 2018

Add to watchlist:

No watchlists yet
View on USPTO

BICYCLE TOXIN CONJUGATES Trademark

Serial Number: 79237920 • Registration: 5790509

BICYCLE TOXIN CONJUGATES is a trademark filed by Bicycletx Limited on March 9, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Bicycletx Limited (33 trademarks)

Blocks A & B Portway Building,

Entity Type: 99

Bicycle Therapeutics Limited (8 trademarks)

Meditrina Building,

Entity Type: 99

Trademark Details

Filing Date

March 9, 2018

Registration Date

July 2, 2019

Published for Opposition

April 16, 2019

Cancellation Date

January 16, 2026

Goods & Services

Scientific and technological services and research and design relating thereto, namely, scientific research, new product design services, and new study design services in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; industrial analysis and research services in the fields of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; information, consultancy and advisory services relating to the aforesaid

Pharmaceutical products, namely, pharmaceutical preparations for use in oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders; pharmaceutical preparations for use as diagnostics, namely, diagnostic preparations for medical use and for use as clinical imaging agents

Filing History

CANCELLED SECTION 71
Jan 16, 2026 C71T
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 26, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 26, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 26, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 26, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 26, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 26, 2025 COAR
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 2, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Dec 1, 2023 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 24, 2022 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Sep 17, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 15, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 24, 2019 FICS
FINAL DISPOSITION PROCESSED
Oct 24, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 2, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 2, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 16, 2019 NPUB
PUBLISHED FOR OPPOSITION
Apr 16, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 27, 2019 NONP
CHANGE OF OWNER RECEIVED FROM IB
Mar 21, 2019 CHLD
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 1, 2019 CNSA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 21, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 21, 2019 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 21, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 21, 2019 TROA
REFUSAL PROCESSED BY IB
Sep 8, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 21, 2018 RFCS
REFUSAL PROCESSED BY MPU
Aug 21, 2018 RFRR
APPLICATION FILING RECEIPT MAILED
Aug 11, 2018 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 10, 2018 RFCR
NON-FINAL ACTION WRITTEN
Aug 9, 2018 CNRT
ASSIGNED TO EXAMINER
Aug 7, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 2, 2018 REPR